GlassScriptPhysician profile
Terry Jean Ward
NPI 1578339339
$2,377.62
in general payments reported to CMS, 2019-2025
8 companies · $1,677 in 2025
The $1,677 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $700 · 2025: $1,677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,395 · Travel and Lodging: $982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,395.49 |
| Travel and Lodging | $982.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,409.67 | 2025 | Linq II |
| Boston Scientific Corporation | $437.19 | 2024-2025 | Eluvia, Farapulse, Watchman Access System |
| Inari Medical, INC. | $250.19 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Biosense Webster, INC. | $114.32 | 2024 | Carto 3, Soundstar |
| Biotronik INC. | $81.35 | 2024 | Amvia Edge |
| Stryker Corporation | $44.36 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $23.42 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.12 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.